nodes	percent_of_prediction	percent_of_DWPC	metapath
Naphazoline—ADRA2C—Amine ligand-binding receptors—HTR2A—narcolepsy	0.0103	0.0104	CbGpPWpGaD
Naphazoline—ADRA2A—Monoamine GPCRs—HTR2A—narcolepsy	0.00997	0.0101	CbGpPWpGaD
Naphazoline—ADRA1A—G alpha (q) signalling events—HCRTR1—narcolepsy	0.00985	0.00994	CbGpPWpGaD
Naphazoline—ADRA1A—G alpha (q) signalling events—HCRTR2—narcolepsy	0.00985	0.00994	CbGpPWpGaD
Naphazoline—Duloxetine—HTR2A—narcolepsy	0.00982	1	CrCbGaD
Naphazoline—ADRA1A—G alpha (q) signalling events—P2RY11—narcolepsy	0.00951	0.0096	CbGpPWpGaD
Naphazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00932	0.00941	CbGpPWpGaD
Naphazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00932	0.00941	CbGpPWpGaD
Naphazoline—ADRA1A—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00902	0.00911	CbGpPWpGaD
Naphazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.009	0.00909	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR1—narcolepsy	0.00881	0.00889	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRTR2—narcolepsy	0.00881	0.00889	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00871	0.00879	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00871	0.00879	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—P2RY11—narcolepsy	0.0085	0.00859	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00841	0.00849	CbGpPWpGaD
Naphazoline—ADRA2A—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00838	0.00846	CbGpPWpGaD
Naphazoline—ADRA1A—G alpha (q) signalling events—HCRT—narcolepsy	0.00809	0.00817	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00798	0.00806	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00798	0.00806	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00771	0.00779	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00761	0.00769	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00761	0.00769	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00746	0.00753	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00746	0.00753	CbGpPWpGaD
Naphazoline—ADRA2B—G alpha (i) signalling events—PENK—narcolepsy	0.00735	0.00742	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00735	0.00742	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HCRT—narcolepsy	0.00723	0.0073	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0072	0.00728	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.00707	0.00714	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.00707	0.00714	CbGpPWpGaD
Naphazoline—ADRA2C—G alpha (i) signalling events—PENK—narcolepsy	0.00687	0.00693	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.00683	0.0069	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00656	0.00662	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00652	0.00659	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00652	0.00659	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.0063	0.00636	CbGpPWpGaD
Naphazoline—ADRA1A—G alpha (q) signalling events—TRH—narcolepsy	0.00613	0.00619	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00613	0.00619	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—HCRTR1—narcolepsy	0.00608	0.00614	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—HCRTR2—narcolepsy	0.00608	0.00614	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.00606	0.00612	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.00606	0.00612	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—P2RY11—narcolepsy	0.00587	0.00593	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.00585	0.00591	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00584	0.0059	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—HCRTR2—narcolepsy	0.00568	0.00574	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—HCRTR1—narcolepsy	0.00568	0.00574	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—PENK—narcolepsy	0.00558	0.00563	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—P2RY11—narcolepsy	0.00549	0.00554	CbGpPWpGaD
Naphazoline—ADRA2B—G alpha (i) signalling events—HRH3—narcolepsy	0.00548	0.00553	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TRH—narcolepsy	0.00548	0.00553	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00546	0.00551	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00535	0.00541	CbGpPWpGaD
Naphazoline—ADRA2C—G alpha (i) signalling events—HRH3—narcolepsy	0.00512	0.00517	CbGpPWpGaD
Naphazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00509	0.00514	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—HCRT—narcolepsy	0.00499	0.00504	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.00498	0.00502	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00497	0.00502	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—HCRTR1—narcolepsy	0.00497	0.00501	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—HCRTR2—narcolepsy	0.00497	0.00501	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—P2RY11—narcolepsy	0.0048	0.00484	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00477	0.00482	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00475	0.0048	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—HCRT—narcolepsy	0.00466	0.00471	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00464	0.00469	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—HCRTR1—narcolepsy	0.00461	0.00466	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—HCRTR2—narcolepsy	0.00461	0.00466	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—P2RY11—narcolepsy	0.00446	0.0045	CbGpPWpGaD
Naphazoline—ADRA1A—G alpha (q) signalling events—TAC1—narcolepsy	0.00445	0.0045	CbGpPWpGaD
Naphazoline—ADRA1A—G alpha (q) signalling events—NPS—narcolepsy	0.00445	0.0045	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—PENK—narcolepsy	0.00445	0.00449	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.00443	0.00448	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00436	0.0044	CbGpPWpGaD
Naphazoline—ADRA2A—G alpha (i) signalling events—HRH3—narcolepsy	0.00416	0.0042	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—PENK—narcolepsy	0.00416	0.0042	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00415	0.00419	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—HCRT—narcolepsy	0.00408	0.00412	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00407	0.00411	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00406	0.0041	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—narcolepsy	0.00398	0.00402	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—narcolepsy	0.00398	0.00402	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00386	0.0039	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—HCRT—narcolepsy	0.00379	0.00383	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—TRH—narcolepsy	0.00378	0.00382	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.00377	0.00381	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—PENK—narcolepsy	0.00363	0.00367	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00361	0.00365	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00361	0.00365	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00356	0.00359	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—TRH—narcolepsy	0.00353	0.00357	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—HCRTR1—narcolepsy	0.00344	0.00347	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—HCRTR2—narcolepsy	0.00344	0.00347	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—PENK—narcolepsy	0.00338	0.00341	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00337	0.00341	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00337	0.00341	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—P2RY11—narcolepsy	0.00332	0.00335	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—HRH3—narcolepsy	0.00332	0.00335	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.00331	0.00334	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—HCRTR2—narcolepsy	0.00321	0.00324	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—HCRTR1—narcolepsy	0.00321	0.00324	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—HCRTR1—narcolepsy	0.00312	0.00315	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—HCRTR2—narcolepsy	0.00312	0.00315	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—P2RY11—narcolepsy	0.0031	0.00313	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—HRH3—narcolepsy	0.0031	0.00313	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—TRH—narcolepsy	0.00309	0.00312	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—P2RY11—narcolepsy	0.00301	0.00304	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00295	0.00298	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00295	0.00298	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—HCRTR2—narcolepsy	0.00291	0.00294	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—HCRTR1—narcolepsy	0.00291	0.00294	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—TRH—narcolepsy	0.00287	0.0029	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—HCRT—narcolepsy	0.00282	0.00285	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—P2RY11—narcolepsy	0.00282	0.00284	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00281	0.00283	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00281	0.00283	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—NPS—narcolepsy	0.00275	0.00278	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—TAC1—narcolepsy	0.00275	0.00278	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.00274	0.00277	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.00274	0.00277	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—P2RY11—narcolepsy	0.00271	0.00274	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—HRH3—narcolepsy	0.00271	0.00274	CbGpPWpGaD
Naphazoline—ADRA1A—G alpha (q) signalling events—HTR2A—narcolepsy	0.00268	0.0027	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—HCRT—narcolepsy	0.00264	0.00266	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—HCRTR2—narcolepsy	0.00261	0.00263	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—HCRTR1—narcolepsy	0.00261	0.00263	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—TAC1—narcolepsy	0.00257	0.00259	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—NPS—narcolepsy	0.00257	0.00259	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—HCRT—narcolepsy	0.00256	0.00259	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HCRTR2—narcolepsy	0.00255	0.00257	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HCRTR1—narcolepsy	0.00255	0.00257	CbGpPWpGaD
Naphazoline—ADRA2B—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00254	0.00256	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—P2RY11—narcolepsy	0.00252	0.00254	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—HRH3—narcolepsy	0.00252	0.00254	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—PENK—narcolepsy	0.00252	0.00254	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—P2RY11—narcolepsy	0.00246	0.00249	CbGpPWpGaD
Naphazoline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—narcolepsy	0.0024	0.00242	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—HCRT—narcolepsy	0.00239	0.00242	CbGpPWpGaD
Naphazoline—ADRA2C—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00237	0.00239	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HCRTR1—narcolepsy	0.00237	0.00239	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HCRTR2—narcolepsy	0.00237	0.00239	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—PENK—narcolepsy	0.00235	0.00237	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CHKB—narcolepsy	0.00234	0.00236	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—HCRT—narcolepsy	0.0023	0.00233	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—P2RY11—narcolepsy	0.00229	0.00231	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—PENK—narcolepsy	0.00228	0.00231	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—NPS—narcolepsy	0.00225	0.00227	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—TAC1—narcolepsy	0.00225	0.00227	CbGpPWpGaD
Naphazoline—ADRA2B—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00217	0.00219	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—HCRT—narcolepsy	0.00214	0.00216	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—TRH—narcolepsy	0.00214	0.00216	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—PENK—narcolepsy	0.00213	0.00215	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HCRT—narcolepsy	0.00209	0.00211	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—NPS—narcolepsy	0.00209	0.00211	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—TAC1—narcolepsy	0.00209	0.00211	CbGpPWpGaD
Naphazoline—ADRA1A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00207	0.00209	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—PENK—narcolepsy	0.00205	0.00207	CbGpPWpGaD
Naphazoline—ADRA2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00203	0.00205	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—TRH—narcolepsy	0.002	0.00202	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HCRT—narcolepsy	0.00194	0.00196	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—TRH—narcolepsy	0.00194	0.00196	CbGpPWpGaD
Naphazoline—ADRA2A—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.00192	0.00194	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—PENK—narcolepsy	0.00191	0.00193	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CHKB—narcolepsy	0.0019	0.00192	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—HRH3—narcolepsy	0.00188	0.00189	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—PENK—narcolepsy	0.00187	0.00188	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HCRTR2—narcolepsy	0.00184	0.00186	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HCRTR1—narcolepsy	0.00184	0.00186	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—TRH—narcolepsy	0.00181	0.00183	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—P2RY11—narcolepsy	0.00178	0.0018	CbGpPWpGaD
Naphazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00177	0.00179	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—HRH3—narcolepsy	0.00175	0.00177	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—TRH—narcolepsy	0.00175	0.00176	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—PENK—narcolepsy	0.00173	0.00175	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HCRTR1—narcolepsy	0.00172	0.00174	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HCRTR2—narcolepsy	0.00172	0.00174	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—HRH3—narcolepsy	0.0017	0.00172	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—P2RY11—narcolepsy	0.00166	0.00168	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR ligand binding—HTR2A—narcolepsy	0.00165	0.00167	CbGpPWpGaD
Naphazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.00165	0.00166	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—TRH—narcolepsy	0.00162	0.00164	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—HRH3—narcolepsy	0.00159	0.00161	CbGpPWpGaD
Naphazoline—ADRA2C—Metabolism—CPT1B—narcolepsy	0.00159	0.00161	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—TRH—narcolepsy	0.00159	0.0016	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—TAC1—narcolepsy	0.00155	0.00157	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—NPS—narcolepsy	0.00155	0.00157	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR ligand binding—HTR2A—narcolepsy	0.00155	0.00156	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—HRH3—narcolepsy	0.00153	0.00155	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HCRT—narcolepsy	0.00151	0.00153	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HCRTR2—narcolepsy	0.00151	0.00152	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HCRTR1—narcolepsy	0.00151	0.00152	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—TRH—narcolepsy	0.00147	0.00149	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—P2RY11—narcolepsy	0.00145	0.00147	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—TAC1—narcolepsy	0.00145	0.00147	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—NPS—narcolepsy	0.00145	0.00147	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—HRH3—narcolepsy	0.00142	0.00144	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HCRT—narcolepsy	0.00141	0.00143	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—NPS—narcolepsy	0.00141	0.00143	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—TAC1—narcolepsy	0.00141	0.00143	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HCRTR1—narcolepsy	0.0014	0.00141	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HCRTR2—narcolepsy	0.0014	0.00141	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HRH3—narcolepsy	0.00139	0.0014	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—P2RY11—narcolepsy	0.00135	0.00136	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR ligand binding—HTR2A—narcolepsy	0.00135	0.00136	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—PENK—narcolepsy	0.00135	0.00136	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—TAC1—narcolepsy	0.00132	0.00133	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—NPS—narcolepsy	0.00132	0.00133	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HRH3—narcolepsy	0.00129	0.0013	CbGpPWpGaD
Naphazoline—ADRA2A—Metabolism—CPT1B—narcolepsy	0.00129	0.0013	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—NPS—narcolepsy	0.00127	0.00128	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—TAC1—narcolepsy	0.00127	0.00128	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—PENK—narcolepsy	0.00126	0.00127	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR ligand binding—HTR2A—narcolepsy	0.00126	0.00127	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HCRT—narcolepsy	0.00124	0.00125	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—TAC1—narcolepsy	0.00118	0.00119	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—NPS—narcolepsy	0.00118	0.00119	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—TAC1—narcolepsy	0.00115	0.00116	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—NPS—narcolepsy	0.00115	0.00116	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HCRT—narcolepsy	0.00115	0.00116	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TRH—narcolepsy	0.00115	0.00116	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—PENK—narcolepsy	0.0011	0.00111	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TRH—narcolepsy	0.00107	0.00108	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—TAC1—narcolepsy	0.00107	0.00108	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—NPS—narcolepsy	0.00107	0.00108	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—PENK—narcolepsy	0.00102	0.00103	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HRH3—narcolepsy	0.00101	0.00102	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HRH3—narcolepsy	0.00094	0.000949	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TRH—narcolepsy	0.000937	0.000946	CbGpPWpGaD
Naphazoline—ADRA2B—GPCR downstream signaling—HTR2A—narcolepsy	0.000935	0.000944	CbGpPWpGaD
Naphazoline—ADRA2C—GPCR downstream signaling—HTR2A—narcolepsy	0.000873	0.000882	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TRH—narcolepsy	0.00087	0.000879	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling by GPCR—HTR2A—narcolepsy	0.000849	0.000857	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—NPS—narcolepsy	0.000834	0.000842	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—TAC1—narcolepsy	0.000834	0.000842	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HRH3—narcolepsy	0.000821	0.00083	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling by GPCR—HTR2A—narcolepsy	0.000793	0.000801	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—TAC1—narcolepsy	0.000779	0.000786	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—NPS—narcolepsy	0.000779	0.000786	CbGpPWpGaD
Naphazoline—ADRA1A—GPCR downstream signaling—HTR2A—narcolepsy	0.000763	0.000771	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HRH3—narcolepsy	0.000763	0.000771	CbGpPWpGaD
Naphazoline—ADRA2A—GPCR downstream signaling—HTR2A—narcolepsy	0.000709	0.000716	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling by GPCR—HTR2A—narcolepsy	0.000693	0.0007	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—NPS—narcolepsy	0.000681	0.000687	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—TAC1—narcolepsy	0.000681	0.000687	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling by GPCR—HTR2A—narcolepsy	0.000644	0.00065	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—NPS—narcolepsy	0.000632	0.000639	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—TAC1—narcolepsy	0.000632	0.000639	CbGpPWpGaD
Naphazoline—ADRA2B—Signaling Pathways—HTR2A—narcolepsy	0.000501	0.000506	CbGpPWpGaD
Naphazoline—ADRA2C—Signaling Pathways—HTR2A—narcolepsy	0.000468	0.000473	CbGpPWpGaD
Naphazoline—ADRA1A—Signaling Pathways—HTR2A—narcolepsy	0.000409	0.000414	CbGpPWpGaD
Naphazoline—ADRA2A—Signaling Pathways—HTR2A—narcolepsy	0.00038	0.000384	CbGpPWpGaD
